Ad is loading...
CSBTF
Price
$30.00
Change
-$5.23 (-14.85%)
Updated
Nov 15 closing price
DIZTF
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Aug 12 closing price
Ad is loading...

CSBTF vs DIZTF

Header iconCSBTF vs DIZTF Comparison
Open Charts CSBTF vs DIZTFBanner chart's image
Kuros Bioscience
Price$30.00
Change-$5.23 (-14.85%)
Volume$876
CapitalizationN/A
Dignitana AB, MALMO
Price$0.13
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
CSBTF vs DIZTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSBTF vs. DIZTF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSBTF is a Hold and DIZTF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CSBTF: $30.00 vs. DIZTF: $0.13)
Brand notoriety: CSBTF and DIZTF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSBTF: 38% vs. DIZTF: 100%
Market capitalization -- CSBTF: $99.14M vs. DIZTF: $24.08M
CSBTF [@Medical Specialties] is valued at $99.14M. DIZTF’s [@Medical Specialties] market capitalization is $24.08M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSBTF’s FA Score shows that 1 FA rating(s) are green whileDIZTF’s FA Score has 0 green FA rating(s).

  • CSBTF’s FA Score: 1 green, 4 red.
  • DIZTF’s FA Score: 0 green, 5 red.
According to our system of comparison, CSBTF is a better buy in the long-term than DIZTF.

Price Growth

CSBTF (@Medical Specialties) experienced а -7.69% price change this week, while DIZTF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
CSBTF($99.1M) has a higher market cap than DIZTF($24.1M). CSBTF YTD gains are higher at: 679.120 vs. DIZTF (-23.529). DIZTF has higher annual earnings (EBITDA): -3.62M vs. CSBTF (-8.84M). CSBTF has more cash in the bank: 24.1M vs. DIZTF (11.7M). CSBTF has less debt than DIZTF: CSBTF (1.91M) vs DIZTF (9.7M). DIZTF has higher revenues than CSBTF: DIZTF (78.6M) vs CSBTF (18M).
CSBTFDIZTFCSBTF / DIZTF
Capitalization99.1M24.1M411%
EBITDA-8.84M-3.62M244%
Gain YTD679.120-23.529-2,886%
P/E RatioN/AN/A-
Revenue18M78.6M23%
Total Cash24.1M11.7M206%
Total Debt1.91M9.7M20%
FUNDAMENTALS RATINGS
CSBTF vs DIZTF: Fundamental Ratings
CSBTF
DIZTF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
9198
PRICE GROWTH RATING
1..100
3473
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DIZTF's Valuation (56) in the null industry is in the same range as CSBTF (59). This means that DIZTF’s stock grew similarly to CSBTF’s over the last 12 months.

CSBTF's Profit vs Risk Rating (2) in the null industry is significantly better than the same rating for DIZTF (100). This means that CSBTF’s stock grew significantly faster than DIZTF’s over the last 12 months.

CSBTF's SMR Rating (91) in the null industry is in the same range as DIZTF (98). This means that CSBTF’s stock grew similarly to DIZTF’s over the last 12 months.

CSBTF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for DIZTF (73). This means that CSBTF’s stock grew somewhat faster than DIZTF’s over the last 12 months.

CSBTF's P/E Growth Rating (100) in the null industry is in the same range as DIZTF (100). This means that CSBTF’s stock grew similarly to DIZTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABCB69.630.01
+0.01%
Ameris Bancorp
BWFG32.25-0.41
-1.26%
Bankwell Financial Group
VRSN180.88-3.48
-1.89%
VeriSign
METC12.15-0.26
-2.10%
Ramaco Resources
HUSA1.43-0.10
-6.54%
Houston American Energy Corp

CSBTF and

Correlation & Price change

A.I.dvisor tells us that CSBTF and APYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBTF and APYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBTF
1D Price
Change %
CSBTF100%
-14.85%
APYX - CSBTF
22%
Poorly correlated
-2.33%
DIZTF - CSBTF
4%
Poorly correlated
N/A
CHEOY - CSBTF
2%
Poorly correlated
-0.13%
CLPBF - CSBTF
2%
Poorly correlated
N/A
CNVVF - CSBTF
1%
Poorly correlated
N/A
More

DIZTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DIZTF has been loosely correlated with PHCCF. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DIZTF jumps, then PHCCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DIZTF
1D Price
Change %
DIZTF100%
N/A
PHCCF - DIZTF
59%
Loosely correlated
N/A
STIM - DIZTF
31%
Poorly correlated
-10.13%
ECIA - DIZTF
7%
Poorly correlated
N/A
CSBTF - DIZTF
4%
Poorly correlated
-14.85%
CZMWF - DIZTF
4%
Poorly correlated
N/A
More